Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | ||||||||
| Cost of revenue | ||||||||
| Gross profit | ||||||||
| Operating expense | 157.49%4.66M | -49.26%1.81M | -52.98%3.57M | 655.47%7.59M | -55.92%1M | 118.82%2.28M | -12.58%1.04M | 1.19M |
| Selling and administrative expenses | -5.82%1.26M | -54.15%1.34M | -52.32%2.92M | 701.92%6.13M | 6.24%763.83K | -2.17%718.94K | -21.71%734.92K | --938.76K |
| -Selling and marketing expense | 74.55%281.66K | -73.65%161.37K | 96.71%612.29K | 266.24%311.27K | 14.34%84.99K | -6.37%74.33K | -42.59%79.39K | --138.28K |
| -General and administrative expense | -16.83%979.48K | -48.98%1.18M | -60.30%2.31M | 756.47%5.81M | 5.31%678.84K | -1.67%644.61K | -18.11%655.53K | --800.48K |
| Depreciation amortization depletion | ---- | ---- | ---- | ---- | ---- | 65.26%17.48K | 70.84%10.58K | --6.19K |
| -Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | 65.26%17.48K | 70.84%10.58K | --6.19K |
| Other operating expenses | 621.62%3.4M | -27.15%471.15K | -55.74%646.7K | 507.86%1.46M | -84.41%240.35K | 421.61%1.54M | 20.17%295.55K | --245.93K |
| Operating profit | -157.49%-4.66M | 49.26%-1.81M | 52.98%-3.57M | -655.47%-7.59M | 55.92%-1M | -118.82%-2.28M | 12.58%-1.04M | -1.19M |
| Net non-operating interest income (expenses) | -715.52%-607.52K | 131.78%98.7K | 12,687.99%42.58K | 211.21%333 | -98.21%107 | -87.04%5.97K | 5.78%46.08K | 43.56K |
| Non-operating interest income | -13.44%85.44K | 131.78%98.7K | 12,687.99%42.58K | 211.21%333 | -98.21%107 | -87.04%5.97K | 5.78%46.08K | --43.56K |
| Non-operating interest expense | --692.96K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other net income (expenses) | 3,650.13%4.74M | -3.16%126.46K | -32.20%130.58K | -29.14%192.61K | 148.69%271.81K | -631.30%-558.26K | -76.34K | |
| Special income (charges) | ---- | ---- | ---- | 59.13%-10.74K | ---26.28K | ---- | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | -59.13%10.74K | --26.28K | ---- | ---- | ---- |
| Other non-operating income (expenses) | 4,034.65%5.23M | -3.16%126.46K | -35.78%130.58K | -31.78%203.35K | 153.40%298.09K | -631.30%-558.26K | ---76.34K | ---- |
| Income before tax | 66.80%-526.24K | 53.30%-1.59M | 54.09%-3.39M | -909.66%-7.39M | 74.13%-732.26K | -164.19%-2.83M | 6.63%-1.07M | -1.15M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||
| Net income | 66.80%-526.24K | 53.30%-1.59M | 54.09%-3.39M | -909.66%-7.39M | 74.13%-732.26K | -164.19%-2.83M | 6.63%-1.07M | -1.15M |
| Net income continuous operations | 66.80%-526.24K | 53.30%-1.59M | 54.09%-3.39M | -909.66%-7.39M | 74.13%-732.26K | -164.19%-2.83M | 6.63%-1.07M | ---1.15M |
| Noncontrolling interests | ||||||||
| Net income attributable to the company | 66.80%-526.24K | 53.30%-1.59M | 54.09%-3.39M | -909.66%-7.39M | 74.13%-732.26K | -164.19%-2.83M | 6.63%-1.07M | -1.15M |
| Preferred stock dividends | ||||||||
| Other under preferred stock dividend | ||||||||
| Net income attributable to common stockholders | 66.80%-526.24K | 53.30%-1.59M | 54.09%-3.39M | -909.66%-7.39M | 74.13%-732.26K | -164.19%-2.83M | 6.63%-1.07M | -1.15M |
| Diluted earnings per share | 76.06%-0.0017 | 68.02%-0.0071 | 68.86%-0.0222 | -312.14%-0.0713 | 78.07%-0.0173 | -152.88%-0.0789 | 25.36%-0.0312 | -0.0418 |
| Basic earnings per share | 76.06%-0.0017 | 68.02%-0.0071 | 68.86%-0.0222 | -312.14%-0.0713 | 78.07%-0.0173 | -152.88%-0.0789 | 25.36%-0.0312 | -0.0418 |
| Dividend per share | ||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |